Aerpio Pharmaceuticals Announces Inducement Grants

CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (OTCQB: ARPO) (“Aerpio”), a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases, announced today the grant of inducement equity awards to its newly appointed Chief Executive Officer, Stephen Hoffman, M.D., Ph.D., and its newly appointed Chief Financial Officer, Michael Rogers. The awards were approved by Aerpio’s Board of Directors on December 14, 2017 and were granted as an inducement material to